Artificial Intelligence

As firms struggle with AI ROI, Allego's new platform embeds practical intelligence into daily workflows, aiming to bridge the gap between hype and results.

Commvault showcases its unified, AI-enabled platform at Red Hat Summit, aiming to secure hybrid cloud workloads in a booming container market.

HealthVerity's acquisition of Symphony Health unites clinical and commercial data, promising to shatter industry silos and accelerate medical breakthroughs.

Following a key Gartner recognition, Aegis Software is integrating digital twins and AI to move factories from reactive execution to predictive intelligence.

A new survey shows millions embrace permanent freelance careers, but this freedom comes with a hidden tax on their health, family, and future stability.

New research reveals AI is not just hype for manufacturers. Early adopters see real value in months, leaving hesitant competitors far behind.

As unmanaged AI agents create a new security crisis, SlashID launches a platform to govern non-human access and rein in the risks of 'Shadow AI'.

The Alliance Group's new practice targets the CFO's growing pains, offering AI-powered execution to bridge the gap between strategic demands and capacity.

Zywave's Spring 2026 release promises to slash administrative work with new AI agents, but can its execution live up to the ambitious vision for growth?

Following a landmark FDA approval and strong earnings, Axsome must convince investors its momentum can translate into long-term profitability and leadership.

HURST Jaws of Life and Elevat launch Captium IQ, an AI-powered system designed to ensure mission-critical rescue equipment is always ready for action.

Three industry titans launch AlphaDrive, a $100M fund blending VC and private equity to back the next generation of Israeli Cyber-AI startups.

A new alliance of 21 biotech firms aims to forge a national strategy, warning that America's long-held lead in medical innovation is under pressure.

With its 100th study launch and a perfect client retention rate, Atreo's agile RTSM platform is challenging the rigid, slow pace of traditional trial tech.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

Germany's startups attracted €1.7B in Q1 2026, fueled by US investors and a massive bet on artificial intelligence, signaling a new era for its ecosystem.

BMW Group and Quantinuum expand their landmark collaboration, leveraging next-gen quantum computers to revolutionize materials for future electric and fuel cell vehicles.

Backed by Mastercard, Visa, and top VCs, Astrada is building the real-time data infrastructure for the coming age of AI-managed enterprise finance.

With new COO Sarah Campbell and fresh capital, Future Technologies is scaling aggressively to solve the critical 'AI Connectivity Gap' for major industries.